25Feb/100
Extended-Release Mirapex Approved for Parkinson’s Disease (HealthDay)
HealthDay - WEDNESDAY, Feb. 24 (HealthDay News) -- Mirapex ER (pramipexole
dihydrochloride extended-release) has been approved by the U.S. Food and
Drug Administration as a once-daily option to treat early Parkinson's
disease, drug maker Boehringer Ingelheim said in a news release.